Abstract |
In a prospective clinical study of 50 patients with Dengue Shock Syndrome (DSS), we investigated the association of tumor necrosis factor-alpha ( TNF-alpha), interleukin-1beta (IL-1beta), IL-1 receptor antagonist (IL-1Ra), and IL-6 with activation markers of coagulation (F1+2 and TATc) and fibrinolysis (t-PA, PAPc, and D-dimer). We found that TNF-alpha, IL-1beta and Il-1Ra, but not IL-6, concentrations were elevated in the circulation during the early stage of infection and at discharge from hospital. TNF-alpha was significantly associated with D-dimer, an activation marker of fibrinolysis (p < 0.003), but not with activation markers of coagulation. IL-1beta was significantly associated with t-PA (p < 0.03). IL-1Ra was significantly associated with F1+2, TATc (p < 0.04 and p < 0.02, respectively), whereas IL-6 was significantly associated with both, activation markers of coagulation (F1+2; p < 0.03) and fibrinolysis (PAPc; p = 0.002). Our data are in line with studies in bacterial sepsis. In severe dengue virus infection the same cytokines are involved in the onset and regulation of hemostasis.
|
Authors | Catharina Suharti, Eric C M van Gorp, Tatty E Setiati, Wil M V Dolmans, Robert J Djokomoeljanto, C Erik Hack, Cate Hugo ten, Jos W M van der Meer |
Journal | Thrombosis and haemostasis
(Thromb Haemost)
Vol. 87
Issue 1
Pg. 42-6
(Jan 2002)
ISSN: 0340-6245 [Print] Germany |
PMID | 11858187
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antifibrinolytic Agents
- Biomarkers
- Cytokines
- Fibrin Fibrinogen Degradation Products
- IL1RN protein, human
- Interleukin 1 Receptor Antagonist Protein
- Interleukin-1
- Interleukin-6
- Peptide Fragments
- Sialoglycoproteins
- Tumor Necrosis Factor-alpha
- alpha-2-Antiplasmin
- antithrombin III-protease complex
- fibrin fragment D
- plasmin-plasmin inhibitor complex
- prothrombin fragment 1.2
- Antithrombin III
- Prothrombin
- Peptide Hydrolases
- Tissue Plasminogen Activator
- Fibrinolysin
|
Topics |
- Adolescent
- Antifibrinolytic Agents
(analysis)
- Antithrombin III
(analysis)
- Biomarkers
- Child
- Child, Preschool
- Cytokines
(blood, physiology)
- Disease Outbreaks
- Female
- Fibrin Fibrinogen Degradation Products
(analysis)
- Fibrinolysin
(analysis)
- Fibrinolysis
- Hemorrhagic Disorders
(blood, etiology)
- Humans
- Indonesia
(epidemiology)
- Interleukin 1 Receptor Antagonist Protein
- Interleukin-1
(blood, physiology)
- Interleukin-6
(blood, physiology)
- Male
- Peptide Fragments
(analysis)
- Peptide Hydrolases
(analysis)
- Prospective Studies
- Prothrombin
(analysis)
- Severe Dengue
(blood, epidemiology)
- Sialoglycoproteins
(blood, physiology)
- Tissue Plasminogen Activator
(analysis)
- Tumor Necrosis Factor-alpha
(analysis, physiology)
- alpha-2-Antiplasmin
(analysis)
|